SM
TTHI

Senvest Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Senvest Management’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,200
Closed -$48K – 107
2014
Q2 		$48K Buy
+7,200
New +$41.8K ﹤0.01% 92

Other funds holding TTHI

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Senvest Management's TTHI Position: Q3 2014 in Review

Senvest Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2014, closing a stake of 7,200 shares — an estimated $48K sold.

Senvest Management first reported a position in TTHI in Q2 2014 and held it in 1 quarter. The position peaked at $48K in Q2 2014. 17 funds tracked by Wall St. Rank hold TTHI as of Q3 2014.

  • Senvest Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2014 after selling out during the quarter.
  • Senvest Management sold 7,200 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2014, an estimated $48K.
  • Senvest Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2014 and held it in 1 quarter.
  • Senvest Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $48K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2014.

Based on Senvest Management's 13F filing for Q3 2014, filed 13 Nov 2014.